BIO KEY INTERNATIONAL INC 8-K

What Happened

• BIO-key International, Inc. (BKYI) announced it received a Nasdaq notice on June 5, 2026 stating the company had not filed its Quarterly Report on Form 10‑Q for the period ended March 31, 2026, which Nasdaq cited as an additional basis for delisting from the Nasdaq Capital Market.
• The company previously appealed Nasdaq’s May 6, 2026 determination to suspend trading of its common stock; a hearing before the Nasdaq Hearing Panel is scheduled for June 16, 2026.
• BIO-key issued a press release on June 10, 2026 reporting these developments and said it is taking all reasonable measures to regain compliance and remain listed.

Key Details

• Failure to file: Form 10‑Q for quarter ended March 31, 2026 (missed filing under Nasdaq Listing Rule 5250(c)(1)).
• Notice date: Nasdaq sent the delisting notice on June 5, 2026.
• Hearing date: Nasdaq Hearing Panel scheduled to consider the matter on June 16, 2026.
• Prior action: Company appealed Nasdaq’s May 6, 2026 suspension determination and is seeking continued listing.

Why It Matters

• For investors, a Nasdaq delisting or suspension of trading could reduce liquidity in BIO-key shares, limit access to certain investors, and potentially negatively affect the share price.
• The outcome depends on the Nasdaq Hearing Panel’s determination and whether the company can promptly file the required report and meet listing standards; the filing contains no assurance that continued listing will be granted.